@article{kitchin_antibody_2009,
	title = {Antibody persistence in {UK} pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group {C} conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine},
	volume = {27},
	issn = {0264-410X},
	url = {http://www.sciencedirect.com/science/article/pii/S0264410X09009116},
	doi = {10.1016/j.vaccine.2009.06.049},
	abstract = {This open-label, randomised, controlled study examined antibody persistence following infant vaccination at 2, 3 and 4 months of age with either an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Haemophilus influenzae type b (DT5aP-IPV-Hib; Pediacel®) or a whole-cell pertussis (DTwP//Hib + oral poliomyelitis vaccine [OPV]) combination vaccine, given concomitantly with meningococcal serogroup C conjugate (MCC) vaccine, followed by a Hib booster at approximately 15 months of age. Immune responses were sustained to 3.5–4.5 years of age for all antigens contained in Pediacel. Administration of an acellular pertussis-containing quadrivalent pre-school booster (Td5ap-IPV; Repevax®), with or without measles, mumps and rubella (M-M-R™II) vaccine, induced robust antibody responses indicative of protection, regardless of the vaccine used for the primary series. Reactogenicity of Repevax was acceptable and consistent with previous experience.},
	number = {37},
	urldate = {2016-06-14},
	journal = {Vaccine},
	author = {Kitchin, Nicholas and Southern, Joanna and Morris, Rhonwen and Borrow, Ray and Fiquet, Anne and Boisnard, Florence and Thomas, Stéphane and Miller, Elizabeth},
	month = aug,
	year = {2009},
	pages = {5096--5102},
}

{"_id":"higciJedCrghxNzAm","bibbaseid":"kitchin-southern-morris-borrow-fiquet-boisnard-thomas-miller-antibodypersistenceinukpreschoolchildrenfollowingprimaryserieswithanacellularpertussiscontainingpentavalentvaccinegivenconcomitantlywithmeningococcalgroupcconjugatevaccineandresponsetoaboosterdoseofanacellularpertussiscontainingquadrivalentvaccine-2009","author_short":["Kitchin, N.","Southern, J.","Morris, R.","Borrow, R.","Fiquet, A.","Boisnard, F.","Thomas, S.","Miller, E."],"bibdata":{"bibtype":"article","type":"article","title":"Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine","volume":"27","issn":"0264-410X","url":"http://www.sciencedirect.com/science/article/pii/S0264410X09009116","doi":"10.1016/j.vaccine.2009.06.049","abstract":"This open-label, randomised, controlled study examined antibody persistence following infant vaccination at 2, 3 and 4 months of age with either an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Haemophilus influenzae type b (DT5aP-IPV-Hib; Pediacel®) or a whole-cell pertussis (DTwP//Hib + oral poliomyelitis vaccine [OPV]) combination vaccine, given concomitantly with meningococcal serogroup C conjugate (MCC) vaccine, followed by a Hib booster at approximately 15 months of age. Immune responses were sustained to 3.5–4.5 years of age for all antigens contained in Pediacel. Administration of an acellular pertussis-containing quadrivalent pre-school booster (Td5ap-IPV; Repevax®), with or without measles, mumps and rubella (M-M-R™II) vaccine, induced robust antibody responses indicative of protection, regardless of the vaccine used for the primary series. Reactogenicity of Repevax was acceptable and consistent with previous experience.","number":"37","urldate":"2016-06-14","journal":"Vaccine","author":[{"propositions":[],"lastnames":["Kitchin"],"firstnames":["Nicholas"],"suffixes":[]},{"propositions":[],"lastnames":["Southern"],"firstnames":["Joanna"],"suffixes":[]},{"propositions":[],"lastnames":["Morris"],"firstnames":["Rhonwen"],"suffixes":[]},{"propositions":[],"lastnames":["Borrow"],"firstnames":["Ray"],"suffixes":[]},{"propositions":[],"lastnames":["Fiquet"],"firstnames":["Anne"],"suffixes":[]},{"propositions":[],"lastnames":["Boisnard"],"firstnames":["Florence"],"suffixes":[]},{"propositions":[],"lastnames":["Thomas"],"firstnames":["Stéphane"],"suffixes":[]},{"propositions":[],"lastnames":["Miller"],"firstnames":["Elizabeth"],"suffixes":[]}],"month":"August","year":"2009","pages":"5096–5102","bibtex":"@article{kitchin_antibody_2009,\n\ttitle = {Antibody persistence in {UK} pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group {C} conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine},\n\tvolume = {27},\n\tissn = {0264-410X},\n\turl = {http://www.sciencedirect.com/science/article/pii/S0264410X09009116},\n\tdoi = {10.1016/j.vaccine.2009.06.049},\n\tabstract = {This open-label, randomised, controlled study examined antibody persistence following infant vaccination at 2, 3 and 4 months of age with either an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Haemophilus influenzae type b (DT5aP-IPV-Hib; Pediacel®) or a whole-cell pertussis (DTwP//Hib + oral poliomyelitis vaccine [OPV]) combination vaccine, given concomitantly with meningococcal serogroup C conjugate (MCC) vaccine, followed by a Hib booster at approximately 15 months of age. Immune responses were sustained to 3.5–4.5 years of age for all antigens contained in Pediacel. Administration of an acellular pertussis-containing quadrivalent pre-school booster (Td5ap-IPV; Repevax®), with or without measles, mumps and rubella (M-M-R™II) vaccine, induced robust antibody responses indicative of protection, regardless of the vaccine used for the primary series. Reactogenicity of Repevax was acceptable and consistent with previous experience.},\n\tnumber = {37},\n\turldate = {2016-06-14},\n\tjournal = {Vaccine},\n\tauthor = {Kitchin, Nicholas and Southern, Joanna and Morris, Rhonwen and Borrow, Ray and Fiquet, Anne and Boisnard, Florence and Thomas, Stéphane and Miller, Elizabeth},\n\tmonth = aug,\n\tyear = {2009},\n\tpages = {5096--5102},\n}\n\n","author_short":["Kitchin, N.","Southern, J.","Morris, R.","Borrow, R.","Fiquet, A.","Boisnard, F.","Thomas, S.","Miller, E."],"key":"kitchin_antibody_2009","id":"kitchin_antibody_2009","bibbaseid":"kitchin-southern-morris-borrow-fiquet-boisnard-thomas-miller-antibodypersistenceinukpreschoolchildrenfollowingprimaryserieswithanacellularpertussiscontainingpentavalentvaccinegivenconcomitantlywithmeningococcalgroupcconjugatevaccineandresponsetoaboosterdoseofanacellularpertussiscontainingquadrivalentvaccine-2009","role":"author","urls":{"Paper":"http://www.sciencedirect.com/science/article/pii/S0264410X09009116"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/robin.marlow","dataSources":["ix72eqAAMGCuupBaz"],"keywords":[],"search_terms":["antibody","persistence","pre","school","children","following","primary","series","acellular","pertussis","containing","pentavalent","vaccine","given","concomitantly","meningococcal","group","conjugate","vaccine","response","booster","dose","acellular","pertussis","containing","quadrivalent","vaccine","kitchin","southern","morris","borrow","fiquet","boisnard","thomas","miller"],"title":"Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine","year":2009}